Monitor for any future conversion to Schedule 13D or changes in PRIMECAP's position, which would signal a shift from passive to active intent. The increase is consistent with normal portfolio rebalancing by a large asset manager.
XNCR drugs
XNCR drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $35.75entry
- T+1 · 8d ago +7.94%α +5.58% · $38.59
- T+5 · 4d ago +3.75%α +1.15% · $37.09
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
PRIMECAP Management disclosed a passive stake of 9,879,855 shares (13.29%) in Xencor Inc as of September 30, 2026, up from 8,700,000 shares (11.7%) in its prior filing. The increase is routine for a large asset manager and does not signal a change in investment intent.
Key Financial Metrics
Key Facts
- PRIMECAP Management reported beneficial ownership of 9,879,855 shares of Xencor common stock, representing 13.29% of shares outstanding as of September 30, 2026.
- The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
- PRIMECAP Odyssey Aggressive Growth Fund holds more than 5% of the class within the managed accounts.
Financial Impact
Increase of approximately 1,179,855 shares from prior filing; stake value at current market cap ~$345M.
Risk Factors
- No change in investment intent indicated; filing is routine.
- No material financial impact from this passive stake update.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000763212-26-000036 |
| Document: 0000763212-26-000036-index.html | 0000763212-26-000036 |
| Document: 0000763212-26-000036.txt | 0000763212-26-000036 |
Track record
20 reports on XNCR
4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +67.24% at T+60 after the May 5, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $35.40 Now $35.40 +0.00% settles Nov 18
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $39.23 Now $35.40 −9.77% settles Nov 17
- Nov 12, 20264d ago Insider Cluster Neutral 4/10 Entry $37.09 to $35.40 Now $35.40 −4.56% ▼ −4.56% −2.65% vs SPY
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $38.13 to $37.09 Now $35.40 −7.16% ▼ −2.73% −2.36% vs SPY
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $39.97 to $38.13 Now $35.40 −11.43% ▼ −4.60% −4.25% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Viewing Entry $35.75 to $38.59 Now $35.40 −0.98% ▲ +7.94% +5.58% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $34.05 to $35.75 Now $35.40 +3.96% ▲ +4.99% +4.68% vs SPY
- Oct 30, 202617d ago SC 13G/A Bearish 4/10 Entry $29.82 to $29.66 Now $35.40 −18.71% ▲ +0.54% +0.06% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $29.99 to $29.21 Now $35.40 +18.04% ▼ −2.60% −2.22% vs SPY
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $29.18 to $29.99 Now $35.40 +21.32% ▲ +2.78% +2.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers